| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF1A MYO1E MAP2 CD2AP ARFGEF1 MYO1B CLSTN2 CLSTN1 YWHAH HNRNPK B4GALT1 PTPN3 ABLIM1 DST DNM3 FMN2 TTLL1 CALML4 PLEKHH2 FBLIM1 PLK1 FBXW11 | 2.76e-05 | 1099 | 151 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | protein kinase activity | TLK2 CDK18 NPR2 ERBB4 KALRN NEK9 RPS6KC1 JAK1 TLK1 BMX IGF2R KDR PLK1 ULK2 EPHA8 | 5.15e-05 | 600 | 151 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB6 SYT12 CIB3 FSTL5 CLSTN2 CUBN EFHB PKD1L3 CLSTN1 SYT10 SVEP1 FAT1 DST TLL1 ANXA10 CALML4 LTBP3 | 5.35e-05 | 749 | 151 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 5.68e-05 | 2 | 151 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 5.68e-05 | 2 | 151 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | X11-like protein binding | 1.70e-04 | 3 | 151 | 2 | GO:0042988 | |
| GeneOntologyMolecularFunction | natriuretic peptide receptor activity | 1.70e-04 | 3 | 151 | 2 | GO:0016941 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TLK2 CDK18 NPR2 ERBB4 KALRN NEK9 RPS6KC1 JAK1 PNPT1 PARP1 TLK1 BMX IGF2R GYS1 KDR PLK1 ULK2 EPHA8 | 2.64e-04 | 938 | 151 | 18 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TLK2 CDK18 NPR2 ERBB4 KALRN NEK9 RPS6KC1 JAK1 TLK1 BMX IGF2R KDR PLK1 ULK2 EPHA8 | 3.20e-04 | 709 | 151 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | TLK2 CDK18 NPR2 ERBB4 KALRN NEK9 RPS6KC1 JAK1 TLK1 BMX IGF2R KDR PLK1 ULK2 EPHA8 | 6.95e-04 | 764 | 151 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 8.30e-04 | 145 | 151 | 6 | GO:0004713 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | CFH ATP6V1B1 ERBB4 NPR3 PRICKLE1 GIMAP5 CYP11B2 CD2AP CUBN KMT2E IL18R1 NCAPG2 ADCY6 CFHR4 NPHP3 AFP SUV39H1 KDR TRPM8 LTBP3 PPP2R3C JAM3 | 6.69e-06 | 1043 | 150 | 22 | GO:0048871 |
| GeneOntologyBiologicalProcess | cell junction organization | ERBB4 KIF1A KALRN PRICKLE1 DSP CD2AP DVL1 LAMA3 NFASC CLSTN2 CLSTN1 SVEP1 HNRNPK AMIGO1 RHPN1 DST DNM3 KDR SDK1 JAM3 SHISA6 | 7.95e-06 | 974 | 150 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | NPR2 KIF1A MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 NFASC YWHAH HNRNPK AMIGO1 RHPN1 ABLIM1 DST DNM3 KDR ULK2 EPHA8 | 8.06e-06 | 819 | 150 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | NPR2 KIF1A MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 NFASC YWHAH HNRNPK AMIGO1 RHPN1 ABLIM1 DST DNM3 KDR ULK2 EPHA8 | 9.09e-06 | 826 | 150 | 19 | GO:0048858 |
| GeneOntologyBiologicalProcess | mitochondrial genome maintenance | 1.30e-05 | 42 | 150 | 5 | GO:0000002 | |
| GeneOntologyBiologicalProcess | renal system process | 1.36e-05 | 149 | 150 | 8 | GO:0003014 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | NPR2 KIF1A MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 NFASC YWHAH HNRNPK AMIGO1 RHPN1 ABLIM1 FAT1 DST WTIP DNM3 KDR FBLIM1 DNMBP ULK2 EPHA8 | 1.75e-05 | 1194 | 150 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | MAP2 PRICKLE1 ARFGEF1 FAT1 NPHP3 DST UBXN2B PLK1 JAM3 FBXW11 | 1.92e-05 | 257 | 150 | 10 | GO:0007163 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | NPR2 KIF1A MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 NFASC YWHAH HNRNPK AMIGO1 ABLIM1 DST DNM3 KDR ULK2 EPHA8 | 2.21e-05 | 802 | 150 | 18 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CFH ITCH PRICKLE1 DSP GIMAP5 CD2AP LAMA3 NFASC CLSTN2 CLSTN1 SVEP1 AMIGO1 CFHR4 JAK1 FAT1 SERPINB8 BTNL2 ASTN1 FBLIM1 SDK1 JAM3 | 3.55e-05 | 1077 | 150 | 21 | GO:0098609 |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 4.69e-05 | 177 | 150 | 8 | GO:0030010 | |
| GeneOntologyBiologicalProcess | neuron development | CFH NPR2 KIF1A MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 ARFGEF1 NFASC YWHAH ADCY6 HNRNPK AMIGO1 CFHR4 ABLIM1 DST DNM3 KDR MMP2 TBC1D23 ULK2 SDK1 EPHA8 | 5.35e-05 | 1463 | 150 | 25 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | NPR2 KIF1A MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 ARFGEF1 NFASC YWHAH ADCY6 HNRNPK AMIGO1 ABLIM1 DST DNM3 KDR MMP2 TBC1D23 ULK2 SDK1 EPHA8 | 5.50e-05 | 1285 | 150 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | mitochondrial DNA metabolic process | 5.54e-05 | 29 | 150 | 4 | GO:0032042 | |
| GeneOntologyBiologicalProcess | cell junction assembly | ERBB4 PRICKLE1 DVL1 LAMA3 NFASC CLSTN2 CLSTN1 AMIGO1 RHPN1 DST DNM3 KDR SDK1 JAM3 | 7.25e-05 | 569 | 150 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 7.53e-05 | 60 | 150 | 5 | GO:0002920 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 1.06e-04 | 148 | 150 | 7 | GO:1902414 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | NPR2 KIF1A MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 NFASC YWHAH AMIGO1 ABLIM1 DST DNM3 ULK2 EPHA8 | 1.14e-04 | 748 | 150 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | collateral sprouting | 1.47e-04 | 37 | 150 | 4 | GO:0048668 | |
| GeneOntologyBiologicalProcess | axon development | NPR2 MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 NFASC AMIGO1 ABLIM1 DST MMP2 ULK2 EPHA8 | 2.54e-04 | 642 | 150 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | NPR2 MAP2 KALRN PRICKLE1 CD2AP DVL1 LAMA3 NFASC AMIGO1 ABLIM1 DST ULK2 EPHA8 | 2.59e-04 | 566 | 150 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | epithelial cell-cell adhesion | 2.84e-04 | 18 | 150 | 3 | GO:0090136 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 3.12e-04 | 4 | 150 | 2 | GO:0002017 | |
| GeneOntologyCellularComponent | microvillus | ATP6V1B1 ATP6V1B2 MYO1E SLC26A2 NFASC MYO1B CUBN ADCY6 FMN2 CALML4 JAM3 | 1.60e-09 | 123 | 152 | 11 | GO:0005902 |
| GeneOntologyCellularComponent | actin-based cell projection | ATP6V1B1 ATP6V1B2 MYO1E MAP2 SLC26A2 NFASC MYO1B CUBN ADCY6 B4GALT1 FCHSD2 FAT1 FMN2 CALML4 JAM3 | 1.94e-09 | 278 | 152 | 15 | GO:0098858 |
| GeneOntologyCellularComponent | somatodendritic compartment | CFH GAD1 ERBB4 KIF1A MAP2 KALRN CYP11B1 CYP11B2 CD2AP DVL1 NFASC CLSTN2 RRM1 CLSTN1 HNRNPK AMIGO1 CFHR4 BPTF SACS DNM3 ASTN1 KDR SHISA6 FBXW11 EPHA8 | 2.76e-06 | 1228 | 152 | 25 | GO:0036477 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ERBB4 SYT12 MAP2 KALRN PRICKLE1 EIF3E DVL1 CLSTN2 CLSTN1 YWHAH RPS6KC1 ABLIM1 DST DNM3 SHISA6 | 6.65e-06 | 523 | 152 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | asymmetric synapse | ERBB4 MAP2 KALRN PRICKLE1 EIF3E DVL1 CLSTN2 CLSTN1 YWHAH RPS6KC1 ABLIM1 DST DNM3 SHISA6 | 1.06e-05 | 477 | 152 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density | ERBB4 MAP2 KALRN PRICKLE1 EIF3E DVL1 CLSTN2 CLSTN1 RPS6KC1 ABLIM1 DST DNM3 SHISA6 | 2.67e-05 | 451 | 152 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | postsynaptic specialization | ERBB4 MAP2 KALRN PRICKLE1 EIF3E DVL1 CLSTN2 CLSTN1 RPS6KC1 ABLIM1 DST DNM3 SHISA6 | 8.13e-05 | 503 | 152 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | anchoring junction | STARD8 MYO1E DSP CD2AP LAMA3 NFASC YWHAH HNRNPK B4GALT1 JAK1 FCHSD2 FAT1 IGF2R DST WTIP KDR FBLIM1 DNMBP JAM3 | 8.87e-05 | 976 | 152 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | dendrite | ERBB4 KIF1A MAP2 CYP11B1 CYP11B2 CD2AP DVL1 NFASC CLSTN2 CLSTN1 HNRNPK AMIGO1 BPTF SACS DNM3 SHISA6 EPHA8 | 1.73e-04 | 858 | 152 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ERBB4 KIF1A MAP2 CYP11B1 CYP11B2 CD2AP DVL1 NFASC CLSTN2 CLSTN1 HNRNPK AMIGO1 BPTF SACS DNM3 SHISA6 EPHA8 | 1.78e-04 | 860 | 152 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | vesicle membrane | GAD1 ATP6V1B1 ATP6V1B2 ITCH SYT12 KIF1A DSP GIMAP5 TBC1D5 UBR4 ABCB6 NFASC MYO1B CUBN SYT10 B4GALT1 IGF2R SEC24C ANXA10 FMN2 ULK2 EPHA8 | 2.39e-04 | 1325 | 152 | 22 | GO:0012506 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO1E MAP2 KALRN CD2AP MYO1B HNRNPK ABLIM1 DST FMN2 TAF5 PLEKHH2 FBLIM1 JAM3 | 3.07e-04 | 576 | 152 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | external side of plasma membrane | CFH IL13RA2 CUBN BTN3A2 BTN3A1 B4GALT1 CFHR4 BTN3A3 BTNL2 ASTN1 KDR TRPM8 | 4.23e-04 | 519 | 152 | 12 | GO:0009897 |
| GeneOntologyCellularComponent | cell surface | CFH IL13RA2 CLSTN2 CUBN PKD1L3 CLSTN1 VWDE BTN3A2 BTN3A1 B4GALT1 CFHR4 PLA2R1 BTN3A3 IGF2R BTNL2 ASTN1 KDR TRPM8 JAM3 | 4.59e-04 | 1111 | 152 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GAD1 ATP6V1B1 ATP6V1B2 ITCH SYT12 KIF1A DSP GIMAP5 TBC1D5 UBR4 ABCB6 NFASC MYO1B CUBN SYT10 B4GALT1 IGF2R SEC24C FMN2 ULK2 EPHA8 | 5.17e-04 | 1307 | 152 | 21 | GO:0030659 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TLK2 EFCAB6 KIF1A MAP2 DSP CD2AP DVL1 MYO1B EFHB DST DNM3 FMN2 TTLL1 PLK1 JAM3 FBXW11 | 8.68e-04 | 899 | 152 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | desmosome | 1.08e-03 | 28 | 152 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | coated vesicle | 1.31e-03 | 360 | 152 | 9 | GO:0030135 | |
| GeneOntologyCellularComponent | cell-cell junction | MYO1E DSP CD2AP LAMA3 NFASC YWHAH B4GALT1 FAT1 DST WTIP DNMBP JAM3 | 1.31e-03 | 591 | 152 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | symbiont cell surface | 1.43e-03 | 8 | 152 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 1.77e-03 | 237 | 152 | 7 | GO:0030136 | |
| GeneOntologyCellularComponent | side of membrane | CFH IL13RA2 CUBN BTN3A2 BTN3A1 B4GALT1 CFHR4 JAK1 PTPN3 BTN3A3 DST BTNL2 ASTN1 KDR TRPM8 | 1.82e-03 | 875 | 152 | 15 | GO:0098552 |
| GeneOntologyCellularComponent | other organism part | 1.83e-03 | 9 | 152 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | axon | CFH GAD1 KIF1A MAP2 CD2AP DVL1 HAPLN2 NFASC HNRNPK AMIGO1 CFHR4 DST SACS DNM3 FBXW11 | 2.17e-03 | 891 | 152 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | microvillus membrane | 2.64e-03 | 38 | 152 | 3 | GO:0031528 | |
| GeneOntologyCellularComponent | hemidesmosome | 2.77e-03 | 11 | 152 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | paranodal junction | 2.77e-03 | 11 | 152 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | postsynapse | ERBB4 KIF1A MAP2 KALRN PRICKLE1 EIF3E DVL1 CLSTN2 CLSTN1 HNRNPK RPS6KC1 ABLIM1 DST DNM3 SHISA6 SENP7 | 3.07e-03 | 1018 | 152 | 16 | GO:0098794 |
| MousePheno | abnormal glomerular mesangium morphology | 1.01e-05 | 83 | 127 | 7 | MP:0011339 | |
| MousePheno | albuminuria | 2.22e-05 | 63 | 127 | 6 | MP:0002871 | |
| MousePheno | hematuria | 2.27e-05 | 19 | 127 | 4 | MP:0005161 | |
| MousePheno | abnormal urine protein level | 2.44e-05 | 170 | 127 | 9 | MP:0006315 | |
| MousePheno | expanded mesangial matrix | 5.82e-05 | 46 | 127 | 5 | MP:0011353 | |
| MousePheno | abnormal endometrium morphology | 7.92e-05 | 49 | 127 | 5 | MP:0004896 | |
| MousePheno | artery occlusion | 8.19e-05 | 2 | 127 | 2 | MP:0006134 | |
| MousePheno | abnormal urine progesterone level | 8.19e-05 | 2 | 127 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 8.19e-05 | 2 | 127 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 8.19e-05 | 2 | 127 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 8.19e-05 | 2 | 127 | 2 | MP:0011553 | |
| MousePheno | abnormal hepatic portal vein thrombosis | 8.19e-05 | 2 | 127 | 2 | MP:0031159 | |
| MousePheno | increased urine progesterone level | 8.19e-05 | 2 | 127 | 2 | MP:0011546 | |
| MousePheno | white pupil | 8.19e-05 | 2 | 127 | 2 | MP:0006242 | |
| MousePheno | decreased serum complement activity | 8.19e-05 | 2 | 127 | 2 | MP:0012553 | |
| MousePheno | decreased complement C5 level | 8.19e-05 | 2 | 127 | 2 | MP:0012609 | |
| MousePheno | abnormal complement C5 level | 8.19e-05 | 2 | 127 | 2 | MP:0012608 | |
| MousePheno | abnormal mesangial matrix morphology | 9.61e-05 | 51 | 127 | 5 | MP:0011338 | |
| MousePheno | decreased urine osmolality | 1.27e-04 | 54 | 127 | 5 | MP:0002988 | |
| MousePheno | abnormal kidney venous thrombosis | 2.44e-04 | 3 | 127 | 2 | MP:0031161 | |
| MousePheno | increased susceptilbility to retina ischemic injury | 2.44e-04 | 3 | 127 | 2 | MP:0012049 | |
| MousePheno | endometrium hyperplasia | 2.48e-04 | 14 | 127 | 3 | MP:0009092 | |
| MousePheno | abnormal urine osmolality | 3.05e-04 | 65 | 127 | 5 | MP:0002987 | |
| MousePheno | abnormal urine homeostasis | CFH ATP6V1B1 NPR3 MYO1E CYP11B1 CYP11B2 CD2AP ADCY6 B4GALT1 CFHR4 JAK1 RHPN1 WTIP | 3.18e-04 | 466 | 127 | 13 | MP:0009643 |
| MousePheno | abnormal renal corpuscle morphology | 3.39e-04 | 293 | 127 | 10 | MP:0002827 | |
| MousePheno | abnormal hemoglobin content | CFH ATP6V1B2 NPR3 ITCH MYO1E GIMAP5 KMT2E SVEP1 B4GALT1 CFHR4 JAK1 RHPN1 | 3.39e-04 | 408 | 127 | 12 | MP:0005563 |
| MousePheno | increased urine protein level | 4.17e-04 | 149 | 127 | 7 | MP:0002962 | |
| MousePheno | abnormal renal glomerular capsule morphology | 4.27e-04 | 107 | 127 | 6 | MP:0002828 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 4.32e-04 | 70 | 127 | 5 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 4.32e-04 | 70 | 127 | 5 | MP:0005326 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 4.86e-04 | 4 | 127 | 2 | MP:0008293 | |
| MousePheno | increased susceptibility to type III hypersensitivity reaction | 4.86e-04 | 4 | 127 | 2 | MP:0005615 | |
| MousePheno | decreased urine aldosterone level | 4.86e-04 | 4 | 127 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 4.86e-04 | 4 | 127 | 2 | MP:0011539 | |
| MousePheno | mesangial cell interposition | 4.86e-04 | 4 | 127 | 2 | MP:0011512 | |
| MousePheno | abnormal brain thrombosis | 4.86e-04 | 4 | 127 | 2 | MP:0031168 | |
| MousePheno | abnormal urine corticosterone level | 4.86e-04 | 4 | 127 | 2 | MP:0011548 | |
| MousePheno | abnormal response to retina ischemic injury | 4.86e-04 | 4 | 127 | 2 | MP:0012048 | |
| MousePheno | decreased circulating complement protein level | 4.86e-04 | 4 | 127 | 2 | MP:0020216 | |
| MousePheno | decreased urine hormone level | 4.86e-04 | 4 | 127 | 2 | MP:0014459 | |
| MousePheno | increased creatine level | 4.86e-04 | 4 | 127 | 2 | MP:0010061 | |
| MousePheno | abnormal nephron morphology | CFH MYO1E PRICKLE1 CD2AP NEK9 B4GALT1 CFHR4 JAK1 RHPN1 FAT1 NPHP3 WTIP | 4.99e-04 | 426 | 127 | 12 | MP:0003881 |
| MousePheno | abnormal renal/urinary system physiology | CFH ATP6V1B1 NPR3 MYO1E CYP11B1 CYP11B2 CD2AP ADCY6 B4GALT1 CFHR4 JAK1 RHPN1 PARP1 NPHP3 DST WTIP | 5.54e-04 | 695 | 127 | 16 | MP:0005502 |
| MousePheno | abnormal adrenal gland zona fasciculata morphology | 6.38e-04 | 19 | 127 | 3 | MP:0008294 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 6.66e-04 | 44 | 127 | 4 | MP:0011348 | |
| MousePheno | abnormal kidney cortex morphology | 7.42e-04 | 324 | 127 | 10 | MP:0000521 | |
| MousePheno | abnormal venous thrombosis | 8.04e-04 | 5 | 127 | 2 | MP:0031158 | |
| MousePheno | abnormal lung thrombosis | 8.04e-04 | 5 | 127 | 2 | MP:0031167 | |
| MousePheno | increased adrenal gland zona fasciculata size | 8.04e-04 | 5 | 127 | 2 | MP:0014286 | |
| MousePheno | disheveled coat | 8.57e-04 | 47 | 127 | 4 | MP:0001511 | |
| Domain | IGv | 2.35e-06 | 75 | 150 | 7 | SM00406 | |
| Domain | Ig_V-set | HAPLN2 IL18R1 BTN3A2 BTN3A1 AMIGO1 IGSF10 BTN3A3 BTNL2 KDR JAM3 | 4.83e-06 | 199 | 150 | 10 | IPR013106 |
| Domain | Kinase-like_dom | TLK2 CDK18 NPR2 ERBB4 KALRN NEK9 RPS6KC1 JAK1 TLK1 BMX DST DNM3 KDR PLK1 ULK2 EPHA8 | 7.71e-06 | 542 | 150 | 16 | IPR011009 |
| Domain | IG | KALRN FSTL5 HAPLN2 NFASC IL18R1 BTN3A2 BTN3A1 AMIGO1 IGSF10 BTN3A3 BTNL2 KDR SDK1 JAM3 | 7.80e-06 | 421 | 150 | 14 | SM00409 |
| Domain | Ig_sub | KALRN FSTL5 HAPLN2 NFASC IL18R1 BTN3A2 BTN3A1 AMIGO1 IGSF10 BTN3A3 BTNL2 KDR SDK1 JAM3 | 7.80e-06 | 421 | 150 | 14 | IPR003599 |
| Domain | V-set | 1.81e-05 | 184 | 150 | 9 | PF07686 | |
| Domain | - | IL13RA2 KALRN FSTL5 HAPLN2 NFASC IL18R1 BTN3A2 BTN3A1 AMIGO1 IGSF10 BTN3A3 BTNL2 ASTN1 KDR SDK1 JAM3 EPHA8 | 2.45e-05 | 663 | 150 | 17 | 2.60.40.10 |
| Domain | Prot_kinase_dom | TLK2 CDK18 NPR2 ERBB4 KALRN NEK9 RPS6KC1 JAK1 TLK1 BMX KDR PLK1 ULK2 EPHA8 | 4.10e-05 | 489 | 150 | 14 | IPR000719 |
| Domain | IG_LIKE | KALRN FSTL5 HAPLN2 NFASC IL18R1 BTN3A2 BTN3A1 AMIGO1 IGSF10 BTN3A3 BTNL2 KDR SDK1 JAM3 | 4.29e-05 | 491 | 150 | 14 | PS50835 |
| Domain | PROTEIN_KINASE_DOM | TLK2 CDK18 NPR2 ERBB4 KALRN NEK9 RPS6KC1 JAK1 TLK1 BMX KDR PLK1 ULK2 EPHA8 | 4.48e-05 | 493 | 150 | 14 | PS50011 |
| Domain | Ig-like_fold | IL13RA2 KALRN FSTL5 HAPLN2 NFASC IL18R1 BTN3A2 BTN3A1 AMIGO1 IGSF10 BTN3A3 BTNL2 ASTN1 KDR SDK1 JAM3 EPHA8 | 5.38e-05 | 706 | 150 | 17 | IPR013783 |
| Domain | Ig-like_dom | KALRN FSTL5 HAPLN2 NFASC IL18R1 BTN3A2 BTN3A1 AMIGO1 IGSF10 BTN3A3 BTNL2 KDR SDK1 JAM3 | 5.56e-05 | 503 | 150 | 14 | IPR007110 |
| Domain | Cyt_P450_mitochondrial | 6.41e-05 | 2 | 150 | 2 | IPR002399 | |
| Domain | DVL-1 | 6.41e-05 | 2 | 150 | 2 | IPR008340 | |
| Domain | V-ATPase_su_B/beta | 6.41e-05 | 2 | 150 | 2 | IPR022879 | |
| Domain | ATPase_V1-cplx_bsu | 6.41e-05 | 2 | 150 | 2 | IPR005723 | |
| Domain | PROTEIN_KINASE_ATP | TLK2 CDK18 ERBB4 KALRN NEK9 RPS6KC1 JAK1 TLK1 BMX KDR PLK1 ULK2 EPHA8 | 8.69e-05 | 459 | 150 | 13 | PS00107 |
| Domain | - | 1.17e-04 | 95 | 150 | 6 | 2.60.120.200 | |
| Domain | - | 1.37e-04 | 13 | 150 | 3 | 2.10.10.10 | |
| Domain | Ig_I-set | 1.52e-04 | 190 | 150 | 8 | IPR013098 | |
| Domain | I-set | 1.52e-04 | 190 | 150 | 8 | PF07679 | |
| Domain | FN_type2_col-bd | 1.73e-04 | 14 | 150 | 3 | IPR000562 | |
| Domain | FN2_2 | 1.73e-04 | 14 | 150 | 3 | PS51092 | |
| Domain | FN2_1 | 1.73e-04 | 14 | 150 | 3 | PS00023 | |
| Domain | fn2 | 1.73e-04 | 14 | 150 | 3 | PF00040 | |
| Domain | FN2 | 1.73e-04 | 14 | 150 | 3 | SM00059 | |
| Domain | Calsyntenin | 1.91e-04 | 3 | 150 | 2 | IPR026914 | |
| Domain | ANF_RECEPTORS | 1.91e-04 | 3 | 150 | 2 | PS00458 | |
| Domain | ANPR/GUC | 1.91e-04 | 3 | 150 | 2 | IPR001170 | |
| Domain | Protein_kinase_ATP_BS | 2.50e-04 | 379 | 150 | 11 | IPR017441 | |
| Domain | EGF-like_CS | 2.65e-04 | 261 | 150 | 9 | IPR013032 | |
| Domain | - | 2.65e-04 | 261 | 150 | 9 | 1.10.238.10 | |
| Domain | EGF_2 | 2.96e-04 | 265 | 150 | 9 | PS01186 | |
| Domain | Dishevelled | 3.80e-04 | 4 | 150 | 2 | PF02377 | |
| Domain | Dishevelled_fam | 3.80e-04 | 4 | 150 | 2 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 3.80e-04 | 4 | 150 | 2 | IPR003351 | |
| Domain | ConA-like_dom | 3.98e-04 | 219 | 150 | 8 | IPR013320 | |
| Domain | EF-hand-dom_pair | 5.29e-04 | 287 | 150 | 9 | IPR011992 | |
| Domain | EF_HAND_2 | 5.66e-04 | 231 | 150 | 8 | PS50222 | |
| Domain | Pkinase_Tyr | 6.14e-04 | 129 | 150 | 6 | PF07714 | |
| Domain | ATP_synth_asu_C | 6.31e-04 | 5 | 150 | 2 | IPR000793 | |
| Domain | ATP-synt_ab_N | 6.31e-04 | 5 | 150 | 2 | PF02874 | |
| Domain | ATPase_F1/V1/A1_a/bsu_N | 6.31e-04 | 5 | 150 | 2 | IPR004100 | |
| Domain | ATPase_a/bsu_AS | 6.31e-04 | 5 | 150 | 2 | IPR020003 | |
| Domain | ATP-synt_ab_C | 6.31e-04 | 5 | 150 | 2 | PF00306 | |
| Domain | ATP-synt_ab | 6.31e-04 | 5 | 150 | 2 | PF00006 | |
| Domain | ATPASE_ALPHA_BETA | 6.31e-04 | 5 | 150 | 2 | PS00152 | |
| Domain | EGF | 6.34e-04 | 235 | 150 | 8 | SM00181 | |
| Domain | EGF_CA | 6.45e-04 | 86 | 150 | 5 | PF07645 | |
| Domain | TPR_2 | 6.91e-04 | 50 | 150 | 4 | PF07719 | |
| Domain | TPR_2 | 6.91e-04 | 50 | 150 | 4 | IPR013105 | |
| Domain | Tyr_kinase_cat_dom | 7.17e-04 | 88 | 150 | 5 | IPR020635 | |
| Domain | TyrKc | 7.17e-04 | 88 | 150 | 5 | SM00219 | |
| Domain | TPR_repeat | 7.21e-04 | 133 | 150 | 6 | IPR019734 | |
| Domain | DEP_dom | 7.99e-04 | 23 | 150 | 3 | IPR000591 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 8.74e-04 | 138 | 150 | 6 | IPR001245 | |
| Domain | EGF-like_dom | 9.23e-04 | 249 | 150 | 8 | IPR000742 | |
| Domain | - | 9.41e-04 | 6 | 150 | 2 | 3.90.1290.10 | |
| Domain | ATPase_F1/V1/A1_a/bsu_nucl-bd | 9.41e-04 | 6 | 150 | 2 | IPR000194 | |
| Domain | EGF_1 | 1.08e-03 | 255 | 150 | 8 | PS00022 | |
| Domain | PROTEIN_KINASE_TYR | 1.11e-03 | 97 | 150 | 5 | PS00109 | |
| Domain | EGF_Ca-bd_CS | 1.11e-03 | 97 | 150 | 5 | IPR018097 | |
| Domain | Tyr_kinase_AS | 1.11e-03 | 97 | 150 | 5 | IPR008266 | |
| Domain | EGF_CA | 1.22e-03 | 99 | 150 | 5 | PS01187 | |
| Domain | Plectin | 1.31e-03 | 7 | 150 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.31e-03 | 7 | 150 | 2 | IPR001101 | |
| Domain | Myosin_TH1 | 1.31e-03 | 7 | 150 | 2 | PF06017 | |
| Domain | DIX | 1.31e-03 | 7 | 150 | 2 | PF00778 | |
| Domain | Myosin_TH1 | 1.31e-03 | 7 | 150 | 2 | IPR010926 | |
| Domain | DIX | 1.31e-03 | 7 | 150 | 2 | IPR001158 | |
| Domain | TH1 | 1.31e-03 | 7 | 150 | 2 | PS51757 | |
| Domain | DIX | 1.31e-03 | 7 | 150 | 2 | PS50841 | |
| Domain | DAX | 1.31e-03 | 7 | 150 | 2 | SM00021 | |
| Domain | PLEC | 1.31e-03 | 7 | 150 | 2 | SM00250 | |
| Domain | EF_HAND_1 | 1.32e-03 | 204 | 150 | 7 | PS00018 | |
| Domain | TPR-contain_dom | 1.34e-03 | 150 | 150 | 6 | IPR013026 | |
| Domain | Spectrin_repeat | 1.59e-03 | 29 | 150 | 3 | IPR002017 | |
| Domain | Growth_fac_rcpt_ | 1.64e-03 | 156 | 150 | 6 | IPR009030 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.65e-03 | 106 | 150 | 5 | IPR000152 | |
| Domain | Kringle-like | 2.12e-03 | 32 | 150 | 3 | IPR013806 | |
| Domain | SPEC | 2.12e-03 | 32 | 150 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.12e-03 | 32 | 150 | 3 | IPR018159 | |
| Domain | TPR_REGION | 2.18e-03 | 165 | 150 | 6 | PS50293 | |
| Domain | TPR | 2.18e-03 | 165 | 150 | 6 | PS50005 | |
| Domain | LIM | 2.31e-03 | 69 | 150 | 4 | PF00412 | |
| Domain | PH_dom-like | 2.36e-03 | 426 | 150 | 10 | IPR011993 | |
| Domain | - | 2.43e-03 | 70 | 150 | 4 | 2.10.110.10 | |
| Domain | PH | 2.54e-03 | 229 | 150 | 7 | PF00169 | |
| Domain | LIM | 2.56e-03 | 71 | 150 | 4 | SM00132 | |
| Domain | Znf_LIM | 2.56e-03 | 71 | 150 | 4 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 2.56e-03 | 71 | 150 | 4 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 2.56e-03 | 71 | 150 | 4 | PS50023 | |
| Domain | EF_hand_dom | 2.73e-03 | 232 | 150 | 7 | IPR002048 | |
| Domain | TPR_7 | 2.76e-03 | 10 | 150 | 2 | PF13176 | |
| Domain | EF_Hand_1_Ca_BS | 2.92e-03 | 175 | 150 | 6 | IPR018247 | |
| Domain | IGc2 | 2.94e-03 | 235 | 150 | 7 | SM00408 | |
| Domain | EGF_3 | 2.94e-03 | 235 | 150 | 7 | PS50026 | |
| Domain | Ig_sub2 | 2.94e-03 | 235 | 150 | 7 | IPR003598 | |
| Domain | EGF_CA | 3.05e-03 | 122 | 150 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.27e-03 | 124 | 150 | 5 | IPR001881 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 1.98e-06 | 12 | 115 | 4 | M27738 | |
| Pubmed | CFH ATP6V1B2 AARS1 ITCH SUPT20H TTC28 KIF1A MYO1E KALRN DSP UBR4 NDUFA10 YWHAH HNRNPK JAK1 PARP1 GUF1 ABLIM1 DST SACS CTR9 DNM3 FMN2 ASTN1 LTBP3 TBC1D23 FBXW11 | 1.97e-11 | 1285 | 155 | 27 | 35914814 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CFH NPR3 SYT12 ARFGEF1 RRM1 CLSTN1 TMEM87A NEK9 NCAPG2 BTN3A2 HNRNPK B4GALT1 IGSF10 PLA2R1 FAT1 IGF2R SEC24C P4HA1 TLL1 HS2ST1 LTBP3 MMP2 | 2.08e-08 | 1201 | 155 | 22 | 35696571 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK18 AARS1 ERBB4 ITCH TTC28 MAP2 DSP TBC1D5 CD2AP NEK9 YWHAH PTPN3 ABLIM1 BMX DST FMN2 PLK1 DNMBP | 6.39e-08 | 861 | 155 | 18 | 36931259 |
| Pubmed | TLK2 TPP2 ITCH KALRN TBC1D5 UBR4 NFASC NEK9 YWHAH HNRNPK PARP1 ABLIM1 IGF2R DST SEC24C WTIP KCNJ16 DNM3 TAF5 | 6.63e-08 | 963 | 155 | 19 | 28671696 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 22767497 | ||
| Pubmed | DSP MYO1B NEK9 YWHAH RPS6KC1 JAK1 PARP1 ABLIM1 FAT1 DST P4HA1 PLK1 | 2.76e-07 | 401 | 155 | 12 | 25852190 | |
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 3.46e-07 | 4 | 155 | 3 | 39142074 | |
| Pubmed | 8.39e-07 | 225 | 155 | 9 | 12168954 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 29339503 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ITCH MYO1E SLC26A2 TBC1D5 DOCK9 ARFGEF1 TMEM87A ADCY6 PTPN3 FAT1 IGF2R FMN2 JAM3 | 1.81e-06 | 569 | 155 | 13 | 30639242 |
| Pubmed | ITCH KALRN DSP DOCK9 KMT2E NEK9 HNRNPK ABLIM1 NPHP3 DST P4HA1 MMP2 | 2.60e-06 | 497 | 155 | 12 | 23414517 | |
| Pubmed | 2.61e-06 | 22 | 155 | 4 | 22305495 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 2.72e-06 | 333 | 155 | 10 | 32665550 | |
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 3.00e-06 | 7 | 155 | 3 | 11170752 | |
| Pubmed | ITCH KIF1A SLC26A2 TBC1D5 ARFGEF1 TMEM87A RPS6KC1 IGF2R DST FMN2 JAM3 FBXW11 | 3.00e-06 | 504 | 155 | 12 | 34432599 | |
| Pubmed | AARS1 DSP CD2AP EIF3E THUMPD1 YWHAH HNRNPK PNPT1 PARP1 IGF2R SEC24C MMP2 TAF5 PLK1 FBXW11 | 3.71e-06 | 809 | 155 | 15 | 32129710 | |
| Pubmed | TPP2 ATP6V1B2 AARS1 NPR3 ITCH DSP UBR4 MYO1B RRM1 NDUFA10 JAK1 BPTF PARP1 FAT1 IGF2R DST SEC24C P4HA1 GYS1 | 5.61e-06 | 1297 | 155 | 19 | 33545068 | |
| Pubmed | 7.15e-06 | 9 | 155 | 3 | 12482924 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 ITCH KIF1A MAP2 ABHD2 TBC1D5 CD2AP LAMA3 NFASC NEK9 B4GALT1 BPTF ABLIM1 TLK1 SPIN1 TLL1 HS2ST1 WDR45B ADGRD1 FBXW11 | 1.12e-05 | 1489 | 155 | 20 | 28611215 |
| Pubmed | 1.40e-05 | 11 | 155 | 3 | 17360631 | ||
| Pubmed | Neddylation modification of the U3 snoRNA-binding protein RRP9 by Smurf1 promotes tumorigenesis. | 1.48e-05 | 117 | 155 | 6 | 34662580 | |
| Pubmed | 1.54e-05 | 322 | 155 | 9 | 26514267 | ||
| Pubmed | TTC28 DOCK9 FSTL5 ADCY6 ABLIM1 FCHSD2 SEC24C DNM3 ULK2 SENP7 | 1.57e-05 | 407 | 155 | 10 | 12693553 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPP2 MAP2 UBR4 DVL1 MYO1B YWHAH HNRNPK PARP1 DST SEC24C SACS | 1.58e-05 | 498 | 155 | 11 | 36634849 |
| Pubmed | High-resolution mapping of mouse chromosome 8 identifies an evolutionary chromosomal breakpoint. | 1.85e-05 | 12 | 155 | 3 | 9680377 | |
| Pubmed | 1.85e-05 | 12 | 155 | 3 | 22919064 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.96e-05 | 332 | 155 | 9 | 32786267 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 23150505 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 1.97e-05 | 2 | 155 | 2 | 21164264 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17392376 | ||
| Pubmed | Absence of complement factor H reduces physical performance in C57BL6 mice. | 1.97e-05 | 2 | 155 | 2 | 32962822 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 29310826 | ||
| Pubmed | Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. | 1.97e-05 | 2 | 155 | 2 | 20538999 | |
| Pubmed | Inheritance, hormonal regulation and properties of polymorphic murine antigens Mud1 and Mud2. | 1.97e-05 | 2 | 155 | 2 | 4992636 | |
| Pubmed | Retinal changes precede visual dysfunction in the complement factor H knockout mouse. | 1.97e-05 | 2 | 155 | 2 | 23844226 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11556325 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 21647934 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 8645611 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26374608 | ||
| Pubmed | A gene locus concerned with an antigenic serum substance in Mus musculus. | 1.97e-05 | 2 | 155 | 2 | 4955525 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 2533512 | ||
| Pubmed | Complement factor H: spatial and temporal expression and localization in the eye. | 1.97e-05 | 2 | 155 | 2 | 16936129 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 33558624 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 37940659 | ||
| Pubmed | The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation. | 1.97e-05 | 2 | 155 | 2 | 17463226 | |
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 1.97e-05 | 2 | 155 | 2 | 12231255 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19620346 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 20634641 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 30705315 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 1303253 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 33859044 | ||
| Pubmed | Regulation of age-related macular degeneration-like pathology by complement factor H. | 1.97e-05 | 2 | 155 | 2 | 25991857 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 24449909 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17898041 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 1741400 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 32755577 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 32540969 | ||
| Pubmed | Serological survey of complement factor H in common laboratory and wild mice: a new third allotype. | 1.97e-05 | 2 | 155 | 2 | 2522412 | |
| Pubmed | Absence of complement factor H alters bone architecture and dynamics. | 1.97e-05 | 2 | 155 | 2 | 30107932 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 34054871 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 9427565 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 36736887 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26047574 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17562771 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26324851 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 27397653 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 29392311 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 22174452 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 7669222 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 22875704 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 22933298 | ||
| Pubmed | Genetic recovery of ErbB4 in adulthood partially restores brain functions in null mice. | 1.97e-05 | 2 | 155 | 2 | 30498032 | |
| Pubmed | Local complement factor H protects kidney endothelial cell structure and function. | 1.97e-05 | 2 | 155 | 2 | 34139209 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 36142803 | ||
| Pubmed | Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis. | 1.97e-05 | 2 | 155 | 2 | 32849636 | |
| Pubmed | Complement factor h is critical in the maintenance of retinal perfusion. | 1.97e-05 | 2 | 155 | 2 | 19541934 | |
| Pubmed | Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. | 1.97e-05 | 2 | 155 | 2 | 17921253 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 2783417 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 24664701 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26149919 | ||
| Pubmed | Murine protein H is comprised of 20 repeating units, 61 amino acids in length. | 1.97e-05 | 2 | 155 | 2 | 2940596 | |
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 1.97e-05 | 2 | 155 | 2 | 2256920 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 32165615 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 20708777 | ||
| Pubmed | Death by color: differential cone loss in the aging mouse retina. | 1.97e-05 | 2 | 155 | 2 | 24929970 | |
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 1.97e-05 | 2 | 155 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 1.97e-05 | 2 | 155 | 2 | 16396990 | |
| Pubmed | Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis. | 1.97e-05 | 2 | 155 | 2 | 23436934 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 23469078 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15574507 | ||
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 1.97e-05 | 2 | 155 | 2 | 18397978 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11306656 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 1518866 | ||
| Pubmed | MLL5 maintains spindle bipolarity by preventing aberrant cytosolic aggregation of PLK1. | 1.97e-05 | 2 | 155 | 2 | 27002166 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 23133374 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 23761669 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 1.97e-05 | 2 | 155 | 2 | 2592361 | |
| Pubmed | Location of the mouse complement factor H gene (cfh) by FISH analysis and replication R-banding. | 1.97e-05 | 2 | 155 | 2 | 1486806 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17517971 | ||
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 2.54e-06 | 15 | 122 | 4 | 458 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.48e-05 | 163 | 122 | 8 | 590 | |
| GeneFamily | Cytochrome P450 family 11 | 1.35e-04 | 3 | 122 | 2 | 1007 | |
| GeneFamily | Cadherin related | 1.90e-04 | 17 | 122 | 3 | 24 | |
| GeneFamily | LIM domain containing | 6.74e-04 | 59 | 122 | 4 | 1218 | |
| GeneFamily | EF-hand domain containing | 7.17e-04 | 219 | 122 | 7 | 863 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.85e-04 | 161 | 122 | 6 | 593 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.09e-03 | 115 | 122 | 5 | 769 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.23e-03 | 8 | 122 | 2 | 939 | |
| GeneFamily | Myosins, class I | 1.23e-03 | 8 | 122 | 2 | 1097 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.75e-03 | 206 | 122 | 6 | 682 | |
| GeneFamily | Fibronectin type III domain containing | 4.61e-03 | 160 | 122 | 5 | 555 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.66e-03 | 50 | 122 | 3 | 1293 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 5.09e-03 | 16 | 122 | 2 | 276 | |
| GeneFamily | Synaptotagmins | 5.75e-03 | 17 | 122 | 2 | 765 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.73e-03 | 57 | 122 | 3 | 1179 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TLK2 ITCH SUPT20H TTC28 DOCK9 CD2AP ARFGEF1 MYO1B TMEM87A DNAJC2 BPTF FCHSD2 TLK1 FAT1 IGF2R DST SACS DNMBP FBXW11 | 6.48e-07 | 856 | 153 | 19 | M4500 |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN | 1.86e-05 | 193 | 153 | 8 | M6150 | |
| Coexpression | GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP | 1.86e-05 | 193 | 153 | 8 | M6143 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 2.16e-05 | 197 | 153 | 8 | M7543 | |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP | 3.21e-05 | 152 | 153 | 7 | M405 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | GAD1 DSP ABHD2 ABCB6 CLSTN1 TMEM87A HNRNPK DNAJC2 YOD1 ABLIM1 FAT1 SERPINB8 DST SPIN1 KCNJ15 LTBP3 | 3.59e-05 | 843 | 153 | 16 | M2356 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 3.64e-05 | 212 | 153 | 8 | M39221 | |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | ERBB4 MYO1E CD2AP NFASC MYO1B PLA2R1 PARP1 TLK1 FAT1 DST ULK2 | 5.47e-05 | 437 | 153 | 11 | M4665 |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 7.06e-05 | 38 | 153 | 4 | M39244 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TLK2 TPP2 KALRN PRICKLE1 SLC26A2 DOCK9 NFASC CUBN ABLIM1 SERPINB8 DST P4HA1 DNM3 FMN2 ASTN1 TBC1D23 ULK2 JAM3 | 8.05e-05 | 1102 | 153 | 18 | M2369 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TLK2 CD2AP ARFGEF1 MYO1B BPTF FCHSD2 TLK1 FAT1 DST DNMBP FBXW11 | 9.67e-05 | 466 | 153 | 11 | M13522 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TLK2 TPP2 KALRN PRICKLE1 SLC26A2 DOCK9 NFASC CUBN ABLIM1 SERPINB8 DST P4HA1 DNM3 FMN2 ASTN1 TBC1D23 ULK2 JAM3 | 1.03e-04 | 1124 | 153 | 18 | MM1070 |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP | 1.23e-04 | 188 | 153 | 7 | M6167 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP | 1.59e-04 | 196 | 153 | 7 | M6156 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.64e-04 | 197 | 153 | 7 | M7545 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 1.64e-04 | 197 | 153 | 7 | M4421 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP | 1.69e-04 | 198 | 153 | 7 | M5152 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 1.74e-04 | 199 | 153 | 7 | M4635 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP | 1.74e-04 | 199 | 153 | 7 | M9306 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN | 1.80e-04 | 200 | 153 | 7 | M8110 | |
| Coexpression | GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP | 1.80e-04 | 200 | 153 | 7 | M5838 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP | 1.80e-04 | 200 | 153 | 7 | M6115 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN | 1.80e-04 | 200 | 153 | 7 | M7744 | |
| Coexpression | GSE17721_LPS_VS_CPG_16H_BMDC_DN | 1.80e-04 | 200 | 153 | 7 | M4009 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 1.80e-04 | 200 | 153 | 7 | M5915 | |
| Coexpression | GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN | 1.80e-04 | 200 | 153 | 7 | M4145 | |
| Coexpression | BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP | 2.03e-04 | 204 | 153 | 7 | M34006 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | TPP2 CASP8AP2 KLHL28 CD2AP EIF3E THUMPD1 RRM1 PNPT1 BTN3A3 TLK1 RSAD2 SACS SPIN1 | 2.05e-04 | 687 | 153 | 13 | M41022 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.95e-09 | 197 | 155 | 10 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-08 | 188 | 155 | 9 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-08 | 188 | 155 | 9 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-08 | 194 | 155 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.19e-08 | 197 | 155 | 9 | 9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 3.33e-08 | 198 | 155 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-07 | 175 | 155 | 8 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 2.44e-07 | 181 | 155 | 8 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-07 | 181 | 155 | 8 | 6c55985e464cb0f5fb3362e9fd90351b671950f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 181 | 155 | 8 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 181 | 155 | 8 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-07 | 185 | 155 | 8 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-07 | 185 | 155 | 8 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 3.01e-07 | 186 | 155 | 8 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.13e-07 | 187 | 155 | 8 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-07 | 189 | 155 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-07 | 191 | 155 | 8 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-07 | 191 | 155 | 8 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.83e-07 | 192 | 155 | 8 | 32927ef3b93e0497e9bbe63c2754da03cf178202 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.98e-07 | 193 | 155 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-07 | 194 | 155 | 8 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.47e-07 | 196 | 155 | 8 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.65e-07 | 197 | 155 | 8 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-07 | 197 | 155 | 8 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.65e-07 | 197 | 155 | 8 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.02e-07 | 199 | 155 | 8 | c5c12c8288fe868322bae9d691b91fee953ceb3e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-07 | 200 | 155 | 8 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.44e-06 | 172 | 155 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-06 | 173 | 155 | 7 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-06 | 175 | 155 | 7 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-06 | 175 | 155 | 7 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-06 | 175 | 155 | 7 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-06 | 175 | 155 | 7 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.06e-06 | 178 | 155 | 7 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-06 | 179 | 155 | 7 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 179 | 155 | 7 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-06 | 179 | 155 | 7 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-06 | 180 | 155 | 7 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.55e-06 | 182 | 155 | 7 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.55e-06 | 182 | 155 | 7 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-06 | 182 | 155 | 7 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-06 | 182 | 155 | 7 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-06 | 182 | 155 | 7 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-06 | 182 | 155 | 7 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.68e-06 | 183 | 155 | 7 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-06 | 184 | 155 | 7 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-06 | 185 | 155 | 7 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-06 | 185 | 155 | 7 | caf4f57f2db9ff72a652c8573e16e7ab180ffc05 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.95e-06 | 185 | 155 | 7 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-06 | 185 | 155 | 7 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 185 | 155 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 186 | 155 | 7 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 186 | 155 | 7 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-06 | 186 | 155 | 7 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-06 | 186 | 155 | 7 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-06 | 186 | 155 | 7 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.39e-06 | 188 | 155 | 7 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.39e-06 | 188 | 155 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.39e-06 | 188 | 155 | 7 | 2b630b0609d4ac61338d6533cb7893cfe1241e44 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-06 | 188 | 155 | 7 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-06 | 189 | 155 | 7 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-06 | 189 | 155 | 7 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-06 | 189 | 155 | 7 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 4.55e-06 | 189 | 155 | 7 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 4.71e-06 | 190 | 155 | 7 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.71e-06 | 190 | 155 | 7 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.87e-06 | 191 | 155 | 7 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 191 | 155 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 191 | 155 | 7 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.87e-06 | 191 | 155 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.04e-06 | 192 | 155 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 192 | 155 | 7 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.04e-06 | 192 | 155 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 192 | 155 | 7 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.04e-06 | 192 | 155 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 192 | 155 | 7 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 193 | 155 | 7 | 8be24713f8ba2545b7647d1994e9e993623ddaa3 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 193 | 155 | 7 | 19dfc4a2c91fcea4f5991e7c44df46faeecb06b8 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 193 | 155 | 7 | 351e0acd411a9eb0dbc0e358d0d1e3759753fa40 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 193 | 155 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.40e-06 | 194 | 155 | 7 | 245a3eb6db9c862b73ad34a8cd2898a3688c16f6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-06 | 194 | 155 | 7 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-06 | 194 | 155 | 7 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-06 | 195 | 155 | 7 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-06 | 195 | 155 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.58e-06 | 195 | 155 | 7 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.58e-06 | 195 | 155 | 7 | fa5fc6f605deb5cae96eec14ba4000b19f877ba6 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.58e-06 | 195 | 155 | 7 | 1e794839a251fbc6e6ce419b4c457ead35a04735 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 5.58e-06 | 195 | 155 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-06 | 195 | 155 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.58e-06 | 195 | 155 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-06 | 196 | 155 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.77e-06 | 196 | 155 | 7 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-06 | 196 | 155 | 7 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.97e-06 | 197 | 155 | 7 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 5.97e-06 | 197 | 155 | 7 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-06 | 197 | 155 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 5.97e-06 | 197 | 155 | 7 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-06 | 197 | 155 | 7 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.97e-06 | 197 | 155 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| Disease | Kyphosis deformity of spine | 1.30e-06 | 5 | 151 | 3 | C0022821 | |
| Disease | Colorectal Carcinoma | STARD8 MAP2 KALRN FSTL5 ARFGEF1 ABCB6 MYO1B CLSTN2 CUBN LIG1 PARP1 FAT1 SACS KDR MMP2 | 3.47e-06 | 702 | 151 | 15 | C0009402 |
| Disease | Intellectual Disability | TLK2 KMT2E HNRNPK BPTF PNPT1 PARP1 SACS ASTN1 WDR45B TBC1D23 FBXW11 | 2.05e-05 | 447 | 151 | 11 | C3714756 |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 2.10e-05 | 11 | 151 | 3 | EFO_0021862 | |
| Disease | Glucocorticoid-remediable aldosteronism | 2.60e-05 | 2 | 151 | 2 | C1260386 | |
| Disease | c3d:C3 ratio | 2.60e-05 | 2 | 151 | 2 | EFO_0008543 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 2.60e-05 | 2 | 151 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | calnexin measurement | 7.78e-05 | 3 | 151 | 2 | EFO_0801444 | |
| Disease | complement factor H-related protein 4A measurement | 7.78e-05 | 3 | 151 | 2 | EFO_0600057 | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 7.78e-05 | 3 | 151 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 7.78e-05 | 3 | 151 | 2 | EFO_0801683 | |
| Disease | interferon gamma measurement | 1.37e-04 | 51 | 151 | 4 | EFO_0008165 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 1.55e-04 | 4 | 151 | 2 | EFO_0803292 | |
| Disease | asthma, Hispanic or Latin American | 1.55e-04 | 4 | 151 | 2 | HANCESTRO_0014, MONDO_0004979 | |
| Disease | kallikrein-5 measurement | 1.55e-04 | 4 | 151 | 2 | EFO_0020515 | |
| Disease | complement factor H-related protein 1 measurement | 1.97e-04 | 56 | 151 | 4 | EFO_0600054 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 2.58e-04 | 5 | 151 | 2 | DOID:446 (is_implicated_in) | |
| Disease | DiGeorge syndrome (is_implicated_in) | 2.58e-04 | 5 | 151 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | follicular lymphoma (implicated_via_orthology) | 2.58e-04 | 5 | 151 | 2 | DOID:0050873 (implicated_via_orthology) | |
| Disease | apolipoprotein L1 measurement | 2.78e-04 | 25 | 151 | 3 | EFO_0021854 | |
| Disease | uromodulin measurement | 3.13e-04 | 26 | 151 | 3 | EFO_0021778 | |
| Disease | macular degeneration (is_implicated_in) | 3.51e-04 | 27 | 151 | 3 | DOID:4448 (is_implicated_in) | |
| Disease | immature platelet measurement | 3.75e-04 | 119 | 151 | 5 | EFO_0803541 | |
| Disease | Conn Syndrome | 3.85e-04 | 6 | 151 | 2 | C1384514 | |
| Disease | complement C1s subcomponent measurement | 3.85e-04 | 6 | 151 | 2 | EFO_0008091 | |
| Disease | Hyperaldosteronism | 3.85e-04 | 6 | 151 | 2 | C0020428 | |
| Disease | hypertension (is_implicated_in) | 4.05e-04 | 121 | 151 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | ERBB4 STARD8 KALRN UBR4 EFCAB13 ABCB6 CUBN BTN3A2 HNRNPK PARP1 AFP TLL1 KCNJ15 KDR MMP2 | 4.24e-04 | 1074 | 151 | 15 | C0006142 |
| Disease | coronary artery disease | CDK18 ERBB4 NPR3 KIF1A DOCK9 EFCAB13 PKD1L3 NEK9 VWDE SVEP1 IGSF10 PARP1 IGF2R TTC29 FMN2 PLEKHH2 | 4.27e-04 | 1194 | 151 | 16 | EFO_0001645 |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 4.35e-04 | 29 | 151 | 3 | DOID:332 (is_marker_for) | |
| Disease | platelet component distribution width | STARD8 SUPT20H KALRN TBC1D5 DOCK9 CD2AP CUBN SVEP1 HNRNPK TLK1 DNM3 TTLL1 | 5.30e-04 | 755 | 151 | 12 | EFO_0007984 |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 5.37e-04 | 7 | 151 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | protocadherin alpha-7 measurement | 5.37e-04 | 7 | 151 | 2 | EFO_0801973 | |
| Disease | osteocalcin measurement | 5.37e-04 | 7 | 151 | 2 | EFO_0010232 | |
| Disease | primary dental caries | 7.00e-04 | 34 | 151 | 3 | EFO_0600095 | |
| Disease | calpastatin measurement | 7.14e-04 | 8 | 151 | 2 | EFO_0008065 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 7.14e-04 | 8 | 151 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | Atypical hemolytic-uremic syndrome | 9.15e-04 | 9 | 151 | 2 | cv:C2931788 | |
| Disease | t-cell surface glycoprotein CD5 measurement | 9.15e-04 | 9 | 151 | 2 | EFO_0803134 | |
| Disease | chronic central serous retinopathy | 9.15e-04 | 9 | 151 | 2 | EFO_0009363 | |
| Disease | Hemolytic-uremic syndrome | 9.15e-04 | 9 | 151 | 2 | cv:C0019061 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 9.15e-04 | 9 | 151 | 2 | EFO_0801766 | |
| Disease | protein FAM163B measurement | 9.15e-04 | 9 | 151 | 2 | EFO_0802936 | |
| Disease | Bone Diseases | 1.14e-03 | 10 | 151 | 2 | C0005940 | |
| Disease | adseverin measurement | 1.14e-03 | 10 | 151 | 2 | EFO_0801358 | |
| Disease | Focal segmental glomerulosclerosis | 1.14e-03 | 10 | 151 | 2 | cv:C0017668 | |
| Disease | androstenedione measurement | 1.14e-03 | 10 | 151 | 2 | EFO_0007972 | |
| Disease | Inherited focal segmental glomerulosclerosis | 1.14e-03 | 10 | 151 | 2 | cv:CN327126 | |
| Disease | osteoarthritis, knee, body mass index | 1.21e-03 | 41 | 151 | 3 | EFO_0004340, EFO_0004616 | |
| Disease | complement factor H measurement | 1.21e-03 | 41 | 151 | 3 | EFO_0008097 | |
| Disease | platelet crit | ZNF487 TTC28 MYO1E KALRN TBC1D5 CUBN NCAPG2 HNRNPK JAK1 PLA2R1 PARP1 FMN2 SENP7 | 1.26e-03 | 952 | 151 | 13 | EFO_0007985 |
| Disease | prostate cancer (is_marker_for) | 1.28e-03 | 156 | 151 | 5 | DOID:10283 (is_marker_for) | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 1.39e-03 | 11 | 151 | 2 | EFO_0801461 | |
| Disease | glycerophosphorylcholine measurement | 1.39e-03 | 11 | 151 | 2 | EFO_0020018 | |
| Disease | hemopexin measurement | 1.39e-03 | 11 | 151 | 2 | EFO_0008149 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 1.39e-03 | 11 | 151 | 2 | cv:CN043612 | |
| Disease | triacylglycerol 58:12 measurement | 1.66e-03 | 12 | 151 | 2 | EFO_0010439 | |
| Disease | ovarian serous carcinoma | 1.70e-03 | 46 | 151 | 3 | EFO_1001516 | |
| Disease | coronary artery disease (is_implicated_in) | 1.77e-03 | 100 | 151 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | anthropometric measurement | 1.77e-03 | 168 | 151 | 5 | EFO_0004302 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 1.96e-03 | 13 | 151 | 2 | cv:C4273714 | |
| Disease | leprosy | 1.97e-03 | 103 | 151 | 4 | EFO_0001054 | |
| Disease | risk-taking behaviour | MAP2 TBC1D5 NFASC KMT2E PKD1L3 BPTF TTC29 WSCD2 SDK1 SHISA6 SENP7 | 1.98e-03 | 764 | 151 | 11 | EFO_0008579 |
| Disease | complement factor H-related protein 4 measurement | 2.04e-03 | 49 | 151 | 3 | EFO_0600091 | |
| Disease | immature platelet count | 2.18e-03 | 106 | 151 | 4 | EFO_0803544 | |
| Disease | alkaline phosphatase measurement | MYO1B PKD1L3 VWDE CFHR4 JAK1 TLK1 NPHP3 BTNL2 FMN2 LTBP3 PLEKHH2 SENP7 EPHA8 | 2.22e-03 | 1015 | 151 | 13 | EFO_0004533 |
| Disease | urinary bladder cancer (is_marker_for) | 2.26e-03 | 107 | 151 | 4 | DOID:11054 (is_marker_for) | |
| Disease | Dupuytren Contracture | 2.34e-03 | 108 | 151 | 4 | EFO_0004229 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.61e-03 | 15 | 151 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | platelet-to-lymphocyte ratio | 2.74e-03 | 363 | 151 | 7 | EFO_0008446 | |
| Disease | pneumonia, COVID-19 | 2.75e-03 | 113 | 151 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | immature platelet fraction | 2.84e-03 | 114 | 151 | 4 | EFO_0009187 | |
| Disease | Hypermetropia, Myopia | 2.94e-03 | 189 | 151 | 5 | HP_0000540, HP_0000545 | |
| Disease | endometriosis (biomarker_via_orthology) | 2.98e-03 | 16 | 151 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | neutrophil collagenase measurement | 2.98e-03 | 16 | 151 | 2 | EFO_0008248 | |
| Disease | sarcoidosis (is_implicated_in) | 2.98e-03 | 16 | 151 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 3.11e-03 | 277 | 151 | 6 | C0009404 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 3.36e-03 | 17 | 151 | 2 | DOID:11984 (is_marker_for) | |
| Disease | colorectal cancer (is_implicated_in) | 3.52e-03 | 121 | 151 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | adenosine monophosphate measurement | 3.77e-03 | 18 | 151 | 2 | EFO_0010454 | |
| Disease | loneliness measurement | 3.84e-03 | 124 | 151 | 4 | EFO_0007865 | |
| Disease | transitional cell carcinoma (is_marker_for) | 4.17e-03 | 63 | 151 | 3 | DOID:2671 (is_marker_for) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 4.20e-03 | 19 | 151 | 2 | DOID:2876 (is_marker_for) | |
| Disease | squamous cell carcinoma (is_marker_for) | 4.20e-03 | 19 | 151 | 2 | DOID:1749 (is_marker_for) | |
| Disease | Adenocarcinoma of lung (disorder) | 4.25e-03 | 206 | 151 | 5 | C0152013 | |
| Disease | waist-hip ratio | CFH ERBB4 NPR3 TTC28 ARFGEF1 BPTF BTNL2 KCNJ15 DNM3 WSCD2 LTBP3 TBC1D23 ANO3 SHISA6 | 4.25e-03 | 1226 | 151 | 14 | EFO_0004343 |
| Disease | vital capacity | CFH KIF1A MYO1E MAP2 DSP KMT2E PKD1L3 SVEP1 PNPT1 DST DNM3 WSCD2 KDR LTBP3 | 4.56e-03 | 1236 | 151 | 14 | EFO_0004312 |
| Disease | Multiple Epiphyseal Dysplasia | 4.65e-03 | 20 | 151 | 2 | C0026760 | |
| Disease | coagulation factor measurement | 4.65e-03 | 20 | 151 | 2 | EFO_0004634 | |
| Disease | breast carcinoma (is_marker_for) | 4.75e-03 | 66 | 151 | 3 | DOID:3459 (is_marker_for) | |
| Disease | myocardial infarction (implicated_via_orthology) | 4.75e-03 | 66 | 151 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | Calcium channel blocker use measurement | 4.89e-03 | 213 | 151 | 5 | EFO_0009930 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVYVDQNKFLCYADT | 146 | Q15303 | |
| GFQEALKDYDYTCFV | 231 | P15291 | |
| NVFNLSFLNCGEYKE | 261 | Q86WK6 | |
| CFYLNQSGLVYENIK | 471 | Q9N2J8 | |
| INECYDGYFQELLVA | 226 | Q9UJ72 | |
| CYFQDGDFYEKALVE | 126 | O00478 | |
| DQINEYKECFSLYDK | 51 | Q96GE6 | |
| GFFIKNGEYLCTLDY | 136 | O14639 | |
| NCNDFQYESKVFYLK | 111 | Q04917 | |
| CYFQDGDFYEKALVE | 126 | O00481 | |
| DGQYRCLFEKDDVYQ | 336 | Q9UIR0 | |
| QAKCYENGAFDEFII | 216 | Q6QNK2 | |
| DLYQVLAAKGYQLEC | 1131 | O43306 | |
| YLDSDLKQYLDHCGN | 221 | Q07002 | |
| FVDYAQKNGYRCAVL | 146 | P08910 | |
| ENKLYLAENYCFDSI | 356 | P51813 | |
| YVNYDCDLNAANIFE | 566 | Q9Y6D6 | |
| CAYFVTEQKLQVGDY | 516 | Q9NP58 | |
| GLKDESLAYIYHCQN | 311 | Q86UB2 | |
| ELEGTYKIYCQNHDE | 861 | Q6XZF7 | |
| CFYDGILLYAEVLNE | 336 | P20594 | |
| FKLNDTLDYECHDGY | 526 | P08603 | |
| KEYCRTLFAYEGTNE | 271 | Q9Y5K6 | |
| QKDYSFTIQAYDCGK | 121 | O94985 | |
| LQKEYTFIIQAYDCG | 116 | Q9H4D0 | |
| YDESKFYIGCDRCQN | 2876 | Q12830 | |
| ATYNDLQVEYGKCQL | 71 | Q9UKL3 | |
| KEGDNDYFTCITKAY | 131 | Q99543 | |
| AQEIADKIYNLFNGY | 1161 | O14525 | |
| DSCIYAKVTYLFDNG | 456 | Q9BYT9 | |
| ALVYSDDKLERNCYF | 201 | P17342 | |
| DYKDFYICVNGSSEN | 206 | Q14627 | |
| DKELAVQYLNTFYGC | 46 | P08253 | |
| EYLFAQGQYDLVKCL | 156 | P23458 | |
| YYCDKNDNGDSYLVL | 496 | P26045 | |
| EECSGQLVFKSDAYY | 296 | P09874 | |
| QLVFKSDAYYCTGDV | 301 | P09874 | |
| FYNCEGKQYLLNLID | 126 | Q8N442 | |
| FYSEAILGKTNQEYC | 196 | Q5VVQ6 | |
| KTEENGENQYTFCYN | 301 | Q8NAB2 | |
| QLDGLEKSFYSFYVC | 206 | Q969Q6 | |
| NLFKAEEYILGDFCF | 81 | Q14517 | |
| IKKNAEFEDQGYYSC | 171 | Q13478 | |
| CEDGYFALEKSNYFG | 666 | Q16787 | |
| IELEYCNGGNLYDKI | 126 | Q8TD19 | |
| FNYYEAKQACEEQDG | 161 | Q9GZV7 | |
| ITGLQSEDEADYYCK | 96 | A0A075B6I6 | |
| SYLTLCNEYGQEKIE | 511 | Q96S38 | |
| DLVDKYQHYEDASCG | 4041 | Q03001 | |
| QYDVSYDTGDKAIQC | 441 | Q99259 | |
| NVYKDYRFLELACDS | 601 | Q9UQ16 | |
| RSENSKGVYCLQYDD | 236 | Q9UKB1 | |
| FYCADSEKQQLEEKY | 341 | Q99712 | |
| DYYALKENEICVSQG | 2331 | O60229 | |
| EITIAFDFDYGNCKY | 441 | Q8IZD2 | |
| KDDSGQYYCIASNDA | 211 | Q9BX67 | |
| ADSRTEFGKYAIYCQ | 1071 | Q8IVE3 | |
| TDYNGNCSLEKFYDD | 106 | O95299 | |
| CTLYVLLKYDDFNAD | 216 | Q8N475 | |
| ADTQELYKNIGDCYL | 91 | Q96F15 | |
| DCFELGKVAYTEADY | 166 | P13674 | |
| GCLYEANDYEEIVFL | 351 | Q9Y3R4 | |
| CNELLVDLIYFYQDG | 161 | Q96MT3 | |
| LFEYAGKDNYCLQIN | 611 | Q96J02 | |
| EYEGEYQCFARNKFG | 111 | O94856 | |
| EIQNCYYDKLRIYDG | 1901 | O60494 | |
| FNKVGVAEEGDYTCY | 2106 | Q6WRI0 | |
| DLYLAATKYICQNFE | 151 | Q9NXS3 | |
| QLGDGSYNLNFYKDE | 206 | Q9BZ29 | |
| YDLKSNGKFAYCDFI | 1371 | Q5THR3 | |
| ANFRGSEKYCYLQNE | 731 | P15924 | |
| SEKYCYLQNEVFGLF | 736 | P15924 | |
| GTCKETFNLYYLESD | 116 | P29322 | |
| YIYRGDKENASQCFE | 351 | Q6PD62 | |
| DCIFQYGDNCIQKIY | 261 | P15538 | |
| YGDNCIQKIYQELAF | 266 | P15538 | |
| VECLYVNFDFDGAQK | 296 | P60228 | |
| CYFQDGDFYEKALVE | 126 | P78410 | |
| VEYQCQSYYELQGSK | 236 | Q92496 | |
| YEDLNTCLQNFGIYL | 546 | Q8IY85 | |
| CKQGFYYDGNLLECV | 1021 | Q9NS15 | |
| FCQLELYVEGLQDYE | 376 | Q8WXU2 | |
| FDYCDVDNDGFINYL | 606 | Q8N7U6 | |
| QNEVYCLDDFYRKFA | 286 | Q8WUP2 | |
| KITFSEQCYYVFGDL | 486 | O14640 | |
| DCIFQYGDNCIQKIY | 261 | P19099 | |
| YGDNCIQKIYQELAF | 266 | P19099 | |
| DASVCFVKALYDYEG | 566 | O94868 | |
| KITFSEQCYYVFGDL | 461 | P54792 | |
| RYLCAGAVDFYNNLE | 211 | P13807 | |
| YYLRNFDEDAGKEQC | 1541 | Q9NZ56 | |
| AAFTCEYKYDGQRAQ | 561 | P18858 | |
| LGSYEFLATVDYCKN | 481 | P53992 | |
| YSDEDICNKYNGAVL | 2096 | Q7Z5N4 | |
| GFNLVYNCDETANLY | 3066 | Q9NZJ4 | |
| CGLFQKLGEYYLQNA | 416 | P02771 | |
| LVYFEICELEANGDY | 1136 | Q12756 | |
| GKEYLFYLNVCGETE | 356 | P11717 | |
| KFHGDQECYYQDDLR | 266 | Q15542 | |
| YLQQKYGESCAEARE | 61 | Q8IV01 | |
| ADVSNQLYACYAIGK | 416 | P21281 | |
| DVSNQLYACYAIGKD | 411 | P15313 | |
| DCGVYLLQYVESFFK | 991 | Q9BQF6 | |
| DEAFGCYYQEKVNLQ | 671 | P52630 | |
| EFFELEGNEVCKYDY | 661 | O43897 | |
| FQNYGEYLDILAISC | 166 | Q8WXG1 | |
| EYFDSLKQYEKNCEG | 921 | Q7Z494 | |
| ESDAVECLNYQHYKG | 126 | P61978 | |
| DGDLYILAQNFFYEK | 336 | Q7LGA3 | |
| LKYYFICQTGDFLDG | 131 | Q7Z443 | |
| KEFECNNSESGYLYC | 106 | Q6ZSJ9 | |
| NAVIAICADGSYYKF | 306 | Q5MNZ6 | |
| YFYDTQVLCNLLAVD | 146 | Q8TCS8 | |
| GDEYTFQKEIEYTCN | 2846 | Q4LDE5 | |
| ELLTAYYNQLCFLDA | 166 | Q8TCX5 | |
| YFGEDARNCAVYKAN | 766 | Q13018 | |
| CYEGQSAYDVADLLK | 631 | Q92502 | |
| SKRNLYDFEVEYLCD | 36 | O43463 | |
| EYCQKFYQAELEELS | 106 | P50452 | |
| YCEGNDLDFYLKQHK | 546 | Q86UE8 | |
| AFKIYDFNNDDYICA | 111 | Q96Q77 | |
| QALYCFDYDLEESGE | 191 | Q86XI2 | |
| QFTFSYENEVCKQDY | 6 | Q5SXH7 | |
| LQDKLQTFYGENFEY | 1101 | Q8N2E2 | |
| TVLEYCEGNDLDFYL | 536 | Q9UKI8 | |
| FCKRSEYIYGENQLQ | 126 | Q14CS0 | |
| KTCFYAEQGGQIYDE | 531 | P49588 | |
| YFVCADKESQLEAYD | 101 | Q5T0L3 | |
| YYGALEASCDLAKEQ | 536 | P23921 | |
| NGEYCKKEEENLLFY | 696 | P50443 | |
| YDGFDCVYGLELNKD | 91 | Q9Y657 | |
| GTQQDCSEYLKYLLD | 516 | Q9P2H5 | |
| EFGDLQFCLSYNDYL | 331 | X6R8R1 | |
| DYVFECEAGTQYQKT | 336 | Q8NEM7 | |
| DIEDLFSLAQYYCSK | 271 | Q9NUY8 | |
| YKVNCLQFEGSVEVY | 321 | Q9NPI9 | |
| EVINHKCDLVNYSYG | 316 | P29144 | |
| VEFDFLGKDCIRYYN | 361 | Q969P6 | |
| ICGKLNFTLQYDYEN | 231 | Q6XYQ8 | |
| DSQLEDLGYCVFNKY | 861 | P11137 | |
| YKCEEYGKAFNESSN | 201 | Q6ZMV8 | |
| FGKYNEYEKACNNSA | 236 | Q9BY31 | |
| EYCNGGDLADYLQAK | 86 | Q8IYT8 | |
| CLGNYQEAVKYYEQD | 646 | Q96AY4 | |
| NECGKAYNRFYLLTE | 231 | P58317 | |
| EKGYYNKASECFQQA | 366 | Q8NA56 | |
| YNVGEKVYCQEDFLY | 266 | A6NIX2 | |
| KVYCQEDFLYSGFQQ | 271 | A6NIX2 | |
| NDTGAYKCFYRETDL | 96 | P35968 | |
| FCYARENEQLLYKQG | 191 | Q92609 | |
| LTYGALVAQLCKDYE | 21 | Q5T215 | |
| ERAKYIGCYLDDTQS | 126 | Q2TBF2 | |
| LIRNCDAEGYFLAQY | 226 | Q7Z2W7 | |
| AGECAAEYLALYQKL | 4176 | Q5T4S7 | |
| KCVEEAYSLLNEYGD | 56 | Q9NXG2 | |
| NNDKHCFECYGYDII | 301 | O95922 | |
| SADCYNEIYNFKAEE | 86 | Q8NBN3 | |
| LKQCFEYNHRGYTEE | 241 | B1APH4 | |
| DYSDKYGLGYQLCDN | 416 | P53350 | |
| YQVEGFVDKNNDLLY | 521 | O43795 | |
| CKALYAYDAQDTDEL | 1056 | Q12965 |